ReviewBioengineering (Basel, Switzerland)2025
A Scoping Review of AI-Based Approaches for Detecting Autism Traits Using Voice and Behavioral Data.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Modelling learning dynamics in autism therapy through explainable multimodal representation learning.Frontiers in neuroscience · 2026Article
- SHAP-based explainable AI framework for autism severity classification using 3D motor biomarkers.Frontiers in psychiatry · 2026Article
- Deep transfer learning and explainable AI framework for autism spectrum disorder detection across multiple datasets.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This scoping review systematically maps the rapidly evolving application of Artificial Intelligence (AI) in Autism Spectrum Disorder (ASD) diagnostics, specifically focusing on computational behavioral phenotyping. Recognizing that observable traits like speech and movement are critical for early, timely intervention, the study synthesizes AI's use across eight key behavioral modalities. These include voice biomarkers, conversational dynamics, linguistic analysis, movement analysis, activity recognition, facial gestures, visual attention, and multimodal approaches. The review analyzed 158 studies published between 2015 and 2025, revealing that modern Machine Learning and Deep Learning techniques demonstrate highly promising diagnostic performance in controlled environments, with reported accuracies of up to 99%. Despite this significant capability, the review identifies critical challenges that impede clinical implementation and generalizability. These persistent limitations include pervasive issues with dataset heterogeneity, gender bias in samples, and small overall sample sizes. By detailing the current landscape of observable data types, computational methodologies, and available datasets, this work establishes a comprehensive overview of AI's current strengths and fundamental weaknesses in ASD diagnosis. The article concludes by providing actionable recommendations aimed at guiding future research toward developing diagnostic solutions that are more inclusive, generalizable, and ultimately applicable in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.